XBB or Gryphon is a new COVID-19 Omicron subvariant that’s soaring in Singapore. Here’s what you need to know about the mutated version of the Omicron variant.
news.yahoo.com
For the past several months,
Omicron subvariants BA.4 and BA.5 have dominated
COVID-19 cases in the U.S. But now, there’s a class of new COVID subvariants on the rise and one in particular is getting plenty of attention. It’s called XBB—or Gryphon—and there’s a chance it could overtake everything else out there.
XBB is getting a lot of buzz because it spreads fast—and seems to be able to evade immunity that people have built up from having a previous COVID-19 infection or getting the vaccine, says William Schaffner, M.D., an infectious disease specialist and professor at the Vanderbilt University School of Medicine. Still, Dr. Schaffner says, “it’s early days and we have a lot to learn.”
Here’s what we know about XBB so far, and why doctors are keeping a close eye on it.
XBB is one of the “new class” of Omicron variants that are spreading fast right now, says Thomas Russo, M.D., professor and chief of infectious disease at the University at Buffalo in New York. That includes BQ.1.1, BQ.1, BQ.1.3, BA.2.3.20, and XBB. “XBB is a hybrid version of two strains of the BA.2 form of Omicron,” explains Amesh A. Adalja, M.D., a senior scholar at the Johns Hopkins Center for Health Security. It’s currently “spreading efficiently in Singapore,” he adds.
XBB is thought to have the best ability to evade antibody protections of these newly emerged COVID variants, according to a
pre-print study from researchers in China. That study said that the new strains of Omicron, and XBB in particular, “are the most antibody-evasive strain tested, far exceeding BA.5 and approaching SARS-CoV-1 level.” (SARS-CoV-1, in case you’re not familiar with it, is the strain of coronavirus that causes
SARS, a respiratory virus that can cause severe illness.)
Meaning, the vaccine and having previously had COVID-19 are not thought to offer the same level of protection against XBB as they have with previous strains of COVID-19. Antibody ******* like
Evusheld and
bebtelovimab may also not be very effective against XBB, the
pre-print study says.
“These variants are evolving to evade protection,” Dr. Russo says. The bivalent booster is “likely going to be protective against severe disease” with XBB, but will be “imperfect against preventing infection," Dr. Russo says. “When it comes to evasion of vaccine protection, it’s important to recognize that vaccine protection is not all or none,” Dr. Adalja says. “Even with immune-evasive variants, vaccine protection against what matters most—severe disease—remains intact.”
XBB variant symptoms
So far, symptoms of XBB seem to be similar to what they’ve been with COVID-19 in general. According to the
Centers for Disease Control and Prevention (CDC), those can include:
· Fever or chills
· Cough
· Shortness of breath or difficulty breathing
· Fatigue
· Muscle or body aches
· Headache
· New loss of taste or smell
· Sore throat
· Congestion or runny nose
· Nausea or vomiting
· Diarrhea
How contagious is the XBB subvariant?
Like other strains of Omicron, XBB is thought to be very contagious. Singapore’s
Ministry of Health notes that the variant now makes up 54% of COVID-19 cases in the country, up from 22% the week before. Singapore’s Ministry of health says that XBB is “at least as transmissible as currently circulating variants” but adds that “there is no evidence that XBB causes more severe illness.”
There are a lot of unknowns about XBB right now. While it’s been detected in the U.S., BA.5 and BA.4.6 continue to be the dominant variants in this country, per
CDC data. Other variants are also started to spread at the same time, Dr. Adalja says, and it’s unclear which will displace BA.4.6 and BA.5 in the U.S., if they will at all. “It’s likely to spread to some degree in the U.S. but unclear if it—or some other related variant such as BQ.1.1—will become dominant,” he says.
......... 
